UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of Solute Carriers on the Pharmacokinetics of CYP3A4 Probes

Clinical pharmacology and therapeutics, 2008-12, Vol.84 (6), p.704-709

2008

Volltextzugriff (PDF)

Kinase Inhibitors: The Reality Behind the Success

Clinical pharmacology and therapeutics, 2017-11, Vol.102 (5), p.726-730

2017

Volltextzugriff (PDF)

Pharmacokinetic Considerations for New Targeted Therapies

Clinical pharmacology and therapeutics, 2009-02, Vol.85 (2), p.208-211

2009

Volltextzugriff (PDF)

Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan

Clinical cancer research, 2005-11, Vol.11 (21), p.7800-7806

2005

Volltextzugriff (PDF)

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Clinical cancer research, 2001-08, Vol.7 (8), p.2292-2300

2001

Volltextzugriff (PDF)

Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1070-1077

2005

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Journal of clinical oncology, 2006-02, Vol.24 (4), p.552-562

2006

Volltextzugriff (PDF)

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Clinical cancer research, 2001-10, Vol.7 (10), p.3229-3238

2001

Volltextzugriff (PDF)

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Clinical cancer research, 2004-03, Vol.10 (6), p.1976-1983

2004

Volltextzugriff (PDF)

Relationship of Systemic Exposure to Unbound Docetaxel and Neutropenia

Clinical pharmacology and therapeutics, 2005-01, Vol.77 (1), p.43-53

2005

Volltextzugriff (PDF)

Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteins

Clinical pharmacology and therapeutics, 2003-10, Vol.74 (4), p.364-371

2003

Volltextzugriff (PDF)

Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7765-7767

2005

Volltextzugriff (PDF)

Tumor targeting by conjugation of DHA to paclitaxel

Journal of controlled release, 2001-07, Vol.74 (1), p.233-236

2001

Volltextzugriff (PDF)

Phase I study of Docosahexaenoic acid-paclitaxel: A taxane-fatty acid conjugate with a unique pharmacology and toxicity profile

Clinical cancer research, 2003-09, Vol.9 (10), p.3589-3597

2003

Volltextzugriff (PDF)

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

Cancer chemotherapy and pharmacology, 2003-03, Vol.51 (3), p.231-239

2003

Volltextzugriff (PDF)

Two Drug Interaction Studies Evaluating the Pharmacokinetics and Toxicity of Pemetrexed When Coadministered with Aspirin or Ibuprofen in Patients with Advanced Cancer

Clinical cancer research, 2006-01, Vol.12 (2), p.536-542

2006

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2604-2613

1999

Volltextzugriff (PDF)

Disposition of Docosahexaenoic acid-paclitaxel, a novel taxane, in blood: In vitro and clinical pharmacokinetic studies

Clinical cancer research, 2003, Vol.9 (1), p.151-159

2003

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of the Mitochondrial-specific Rhodacyanine Dye Analog MKT 077

Clinical cancer research, 2000-01, Vol.6 (1), p.42-49

2000

Volltextzugriff (PDF)

Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002-06, Vol.773 (2), p.183-190

2002

Volltextzugriff (PDF)

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2459-2467

2000

Volltextzugriff (PDF)

Population Pharmacokinetics of Troxacitabine, a Novel Dioxolane Nucleoside Analogue

Clinical cancer research, 2006-04, Vol.12 (7), p.2158-2165

2006

Volltextzugriff (PDF)

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3085-3096

1996

Volltextzugriff (PDF)

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3074-3084

1996

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Irofulven, a Novel Mushroom-Derived Cytotoxin, Administered for Five Consecutive Days Every Four Weeks in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 2000-12, Vol.18 (24), p.4086-4097

2000

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaNeoplasms - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of Solute Carriers on the Pharmacokinetics of CYP3A4 Probes

Kinase Inhibitors: The Reality Behind the Success

Pharmacokinetic Considerations for New Targeted Therapies

Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Relationship of Systemic Exposure to Unbound Docetaxel and Neutropenia

Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteins

Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?

Tumor targeting by conjugation of DHA to paclitaxel

Phase I study of Docosahexaenoic acid-paclitaxel: A taxane-fatty acid conjugate with a unique pharmacology and toxicity profile

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

Two Drug Interaction Studies Evaluating the Pharmacokinetics and Toxicity of Pemetrexed When Coadministered with Aspirin or Ibuprofen in Patients with Advanced Cancer

Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies

Disposition of Docosahexaenoic acid-paclitaxel, a novel taxane, in blood: In vitro and clinical pharmacokinetic studies

A Phase I and Pharmacokinetic Study of the Mitochondrial-specific Rhodacyanine Dye Analog MKT 077

Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography–tandem mass spectrometry

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

Population Pharmacokinetics of Troxacitabine, a Novel Dioxolane Nucleoside Analogue

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Phase I and Pharmacokinetic Study of Irofulven, a Novel Mushroom-Derived Cytotoxin, Administered for Five Consecutive Days Every Four Weeks in Patients With Advanced Solid Malignancies

Aktive Filter

Suchergebnisse filtern